ALEVE-D SINUS Drug Patent Profile
✉ Email this page to a colleague
When do Aleve-d Sinus patents expire, and when can generic versions of Aleve-d Sinus launch?
Aleve-d Sinus is a drug marketed by Bayer and is included in one NDA.
The generic ingredient in ALEVE-D SINUS is naproxen sodium; pseudoephedrine hydrochloride. There are forty-two drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the naproxen sodium; pseudoephedrine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Aleve-d Sinus
A generic version of ALEVE-D SINUS was approved as naproxen sodium; pseudoephedrine hydrochloride by PERRIGO on March 17th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ALEVE-D SINUS?
- What are the global sales for ALEVE-D SINUS?
- What is Average Wholesale Price for ALEVE-D SINUS?
Summary for ALEVE-D SINUS
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | ALEVE-D SINUS at DailyMed |
US Patents and Regulatory Information for ALEVE-D SINUS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer | ALEVE-D SINUS & COLD | naproxen sodium; pseudoephedrine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021076-001 | Nov 29, 1999 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
